Rickettsial retinitis—an Indian perspective

Journal of Ophthalmic Inflammation and Infection

Table 3 Demography, systemic, and ocular presentation and treatment

Sr. no.	Age/sex		Fever			BCVA at presentation		BCVA at the final follow-up		Anterior segment	Posterior segment	Antibiotics	Steroids
			Skin rash	Joint pain	Ocular involvement	BCVA at presentation		BCVA at the final follow-up
			Skin rash	Joint pain	Ocular involvement	OD	OS	OD	OS
1	F	40			27 days	20/60	20/40	20/20	20/20	OU: quiet, AVF: cells+	OU: MFR, M.S.	Doxy	Oral
2	M	27			10 days	20/2000	20/20	20/40	20/20	OS: O.5 cells, AVF: cells+	RE: MFR	Doxy	Oral + OD PST
3	M	16		√	10 days	20/2000	20/80	20/60	20/30	OU: quiet, AVF: cells+	OU: MFR hemorrhages, M.E.	Nil	Oral
4	F	33			21 days	20/2000	20/60	20/30	20/30	OU: quiet, AVF: cells++	OU: MFR, M.E.	Doxy	Oral + OS PST
5	F	23			30 days	20/125	20/2000	20/60	20/60	OU: cells 1 +, AVF: Cells+	OU: MFR, M.E.	Nil	Oral + OU PST
6	M	29	√	√	15 days	20/30	20/20	Lost to follow-up		OD: quiet, AVF: cells+	OD: focal retinitis	Doxy	Oral
7	F	16	√	√	28 days	20/2000	20/800	20/30	20/30	OU: N.G. KPs, cells+, AVF: cells++	OU: MFR, M.E.	Doxy	IVMP + Oral
8	F	34	√		15 days	20/30	20/20	20/20	20/20	OU: quiet, AVF: cells+	OU: MFR	Doxy	Oral + OS PST
9	M	64			27 days	20/80	20/2000	20/30	20/40	OU: N.G. KPs, cells+, AVF: cells+	OU: MFR, M.E.	Doxy	Oral + OD PST
10	F	22	√		30 days	20/6000	20/20	Lost to follow-up		OU: cells+, AVF: cells+	OU: MFR, OD: M.E., D.E.	Nil	Oral

AVF anterior vitreous face, MFR multifocal retinitis, M.E. macular edema, D.E. disc edema, M.S. macular star, PST posterior sub-Tenon’s injection of Triamcinolone, IVMP intravenous methylprednisolone, Doxy doxycycline